Sponsored by Precision ADVANCE, this Endpoints webinar will convene leading advanced therapy experts to discuss the future of CGTx clinical development. This discussion will be moderated by Teresa Pokladowski: Regional VP, Clinical Business Solutions (Precision for Medicine), and include insights from Kinnari Patel: President & COO (Rocket Pharmaceuticals), Suma Krishnan: Founder & President (Kystal Biotech), Dawn Buchanan: VP Clinical Operations (AffyImmune), and Ramona Repaczki-Jones: Executive Director, Commercial Treatment Center Operations, Cell Therapy (lovance Biotherapeutics, Inc).
Key points to be discussed:
- Improving efficiency and quality of clinical research (technology, modeling, simulation)
- Patient access and clinical trial diversity
- Identifying and overcoming key challenges for a successful study execution
- Key considerations for evaluating partners (CROs, vendors, etc.)
